Basis of variable sensitivities of GABAA receptors to ethanol

被引:13
作者
Mori, T [1 ]
Aistrup, GL [1 ]
Nishikawa, K [1 ]
Marszalec, W [1 ]
Yeh, JZ [1 ]
Narahashi, T [1 ]
机构
[1] Northwestern Univ, Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA
关键词
ethanol; alcohol; GABA(A) receptor; channel modulation;
D O I
10.1111/j.1530-0277.2000.tb04638.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The GABA(A) system is believed to be one of the crucial target sites for ethanol. However, in the literature, data using various preparations yielded controversial conclusions regarding the ethanol potency to modulate the activity of GABA(A) receptors. We have previously shown that the potency of n-alcohols to potentiate GABA-induced currents is correlated with their carbon chain length. This correlation was further compared among four cell types in an attempt to explain the variable potencies of ethanol to potentiate GABA responses. Methods: Whole-cell patch clamp experiments were performed to determine and compare the potencies of n-alcohols in potentiating GABA-induced currents in rat dorsal root ganglion (DRG) neurons, human embryonic kidney cells expressing the rat alpha 1 beta 2 gamma 2S or alpha 1 beta 2 gamma 2L subunits, and rat cortical neurons. Results: The GABA(A) receptors of the four cell types tested were all sensitive to n-alcohols, albeit with different potencies and efficacies. The effective concentration to increase GABA-induced currents to 125% of control (EC125) was correlated with the carbon chain length of n-alcohols, but slopes for this relationship are different among DRG neurons, the alpha 1 beta 2 gamma 2S, and crlp2y2L subunits. Thus, the potencies of lower alcohols such as ethanol differed among these cell types although higher alcohols such as n-octanol were almost equally potent. In cortical neurons, however, the relationship was shifted in the direction of longer carbon chains, indicating that their sensitivity was lower than those of the other three cell types. The ethanol EC125 values as obtained by experiments or those by extrapolation (in parenthesis) from the EC125-carbon chain length relationship were: 169 (103) mM for DRG neurons, 501 (333) mM for the alpha 1 beta 2 gamma 2L subunits, 781 (674) mM for the alpha 1 beta 2 gamma 2S subunits, and (1897) mM for cortical neurons. Conclusions: It was concluded that the GABA(A) receptors of these four cell types were basically sensitive to n-alcohols including ethanol but the sensitivity curve was shifted to the lower side in the order of decreasing sensitivity of DRG neurons > alpha 1 beta 2 gamma 2L > alpha 1 beta 2 gamma 2S > cortical neurons.
引用
收藏
页码:965 / 971
页数:7
相关论文
共 50 条
[1]   ETHANOL POTENTIATES THE GABA-A-ACTIVATED CL- CURRENT IN MOUSE HIPPOCAMPAL AND CORTICAL-NEURONS [J].
AGUAYO, LG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (01) :127-130
[2]   Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons [J].
Aistrup, GL ;
Marszalec, W ;
Narahashi, T .
MOLECULAR PHARMACOLOGY, 1999, 55 (01) :39-49
[3]   ANESTHETIC POTENCIES OF PRIMARY ALKANOLS - IMPLICATIONS FOR THE MOLECULAR DIMENSIONS OF THE ANESTHETIC SITE [J].
ALIFIMOFF, JK ;
FIRESTONE, LL ;
MILLER, KW .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (01) :9-16
[4]   Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks [J].
Alkondon, M ;
Pereira, EFR ;
Eisenberg, HM ;
Albuquerque, EX .
JOURNAL OF NEUROSCIENCE, 2000, 20 (01) :66-75
[5]  
Alkondon M, 1999, J NEUROSCI, V19, P2693
[6]  
Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
[7]   CHLORIDE CURRENT INDUCED BY ALCOHOLS IN RAT DORSAL-ROOT GANGLION NEURONS [J].
ARAKAWA, O ;
NAKAHIRO, M ;
NARAHASHI, T .
BRAIN RESEARCH, 1992, 578 (1-2) :275-281
[8]  
Cardoso RA, 1999, J PHARMACOL EXP THER, V289, P774
[9]   ETHANOL POTENTIATES GABA-INDUCED AND GLYCINE-INDUCED CHLORIDE CURRENTS IN CHICK SPINAL-CORD NEURONS [J].
CELENTANO, JJ ;
GIBBS, TT ;
FARB, DH .
BRAIN RESEARCH, 1988, 455 (02) :377-380
[10]  
Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1